Now:HOME > ACADEMIC CONFERENCE >Academic trends
Hematology Branch Blood Disease TCP 100 Cities Diagnosis and Treatment Tour-Chengdu Station Successfully Held
Author:管理员  Addtime:2024-02-26

Over the past decade, thrombocytopenia has gradually received great clinical attention, and the related diagnosis and treatment recommendations have been constantly updated.  

The ITP International Working Group and the American Society of Hematology (ASH) updated their previous consensus and guidelines in 2019, and the Hemostasis and Thrombosis Group of the Hematology Branch of the Chinese Medical Association published the Chinese Guidelines for the Diagnosis and Treatment of Adults with Primary Immune Thrombocytopenia (2020 Edition) in 2020, which was also published in the British Journal of Hematology in 2021. A multicenter, double-blind, randomized controlled study of the efficacy and safety of rhTPO versus eltrombopag in the treatment of adult Chinese patients with primary immune thrombocytopenia (ITP) led by Union Hospital of Tongji Medical College, Huazhong University of Science and Technology, China, was published in the journal Hematology in 2021. “.

The first “Thrombocytopenia Treatment Guidelines for Oncology” published by CSCO in 2022 also provides clinical recommendations for TCP to ensure that oncology patients can complete chemotherapy in sufficient quantity and duration to improve their OS.

Hematopoietic stem cell transplantation has been increasing in recent years, and transplantation has become a preferred treatment for many hematologic diseases. Thrombocytopenia that occurs at various stages of transplantation is also of great clinical importance, and studies have sprung up on how to improve early implantation in patients and ensure the success rate of implantation.

These high-quality evidence-based medical evidences provide further guidance and suggestions for clinical diagnosis and treatment, standardize rational diagnosis and treatment and medication in primary care, and advocate joint decision-making between doctors and patients in order to improve patients' quality of life. Chengdu Hi-Tech Medical Association held the meeting of Hematology Division of Blood Disease TCP Hundred Cities Diagnosis and Treatment Tour - Chengdu Station.